{"id":"https://openalex.org/W3203037871","doi":"https://doi.org/10.1002/bit.27945","title":"Manufacturing a chimpanzee adenovirus\u2010vectored SARS\u2010CoV\u20102 vaccine to meet global needs","display_name":"Manufacturing a chimpanzee adenovirus\u2010vectored SARS\u2010CoV\u20102 vaccine to meet global needs","publication_year":2021,"publication_date":"2021-09-29","ids":{"openalex":"https://openalex.org/W3203037871","doi":"https://doi.org/10.1002/bit.27945","mag":"3203037871","pmid":"https://pubmed.ncbi.nlm.nih.gov/34585736","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8653296"},"language":"en","primary_location":{"id":"doi:10.1002/bit.27945","doi":"https://doi.org/10.1002/bit.27945","is_oa":true,"landing_page_url":"https://doi.org/10.1002/bit.27945","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bit.27945","source":{"id":"https://openalex.org/S151564723","display_name":"Biotechnology and Bioengineering","issn_l":"0006-3592","issn":["0006-3592","1097-0290"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnology and Bioengineering","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bit.27945","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023652131","display_name":"Carina C. D. Joe","orcid":"https://orcid.org/0000-0003-1304-8727","observed_orcids":["https://orcid.org/0000-0003-1304-8727"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210153742","display_name":"Jenner Institute","ror":"https://ror.org/05kwhph67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210153742"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Carina C. D. Joe","raw_affiliation_strings":["Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210153742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110461386","display_name":"Jinlin Jiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jinlin Jiang","raw_affiliation_strings":["Biopharmaceuticals Development R&D, AstraZeneca Gaithersburg Maryland USA","Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceuticals Development R&D, AstraZeneca Gaithersburg Maryland USA","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050388339","display_name":"Thomas A. Linke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Linke","raw_affiliation_strings":["Biopharmaceuticals Development R&D, AstraZeneca Gaithersburg Maryland USA","Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceuticals Development R&D, AstraZeneca Gaithersburg Maryland USA","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101573445","display_name":"Yuanyuan Li","orcid":"https://orcid.org/0000-0002-9143-8029","observed_orcids":["https://orcid.org/0000-0002-9143-8029","https://orcid.org/0000-0002-2877-9568"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210153742","display_name":"Jenner Institute","ror":"https://ror.org/05kwhph67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210153742"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Yuanyuan Li","raw_affiliation_strings":["Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210153742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080348865","display_name":"Sofiya Fedosyuk","orcid":"https://orcid.org/0000-0003-2437-5264","observed_orcids":["https://orcid.org/0000-0003-2437-5264"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210153742","display_name":"Jenner Institute","ror":"https://ror.org/05kwhph67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210153742"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sofiya Fedosyuk","raw_affiliation_strings":["Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210153742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100690498","display_name":"Gaurav Gupta","orcid":"https://orcid.org/0000-0001-7941-0229","observed_orcids":["https://orcid.org/0000-0001-7941-0229"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210153742","display_name":"Jenner Institute","ror":"https://ror.org/05kwhph67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210153742"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gaurav Gupta","raw_affiliation_strings":["Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210153742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112483860","display_name":"Adam Berg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210153742","display_name":"Jenner Institute","ror":"https://ror.org/05kwhph67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210153742"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adam Berg","raw_affiliation_strings":["Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210153742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055697536","display_name":"Rameswara  Reddy Segireddy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210153742","display_name":"Jenner Institute","ror":"https://ror.org/05kwhph67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210153742"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rameswara R. Segireddy","raw_affiliation_strings":["Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210153742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020131371","display_name":"David O. Mainwaring","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210154917","display_name":"Pall Corporation (United Kingdom)","ror":"https://ror.org/04hw9y579","country_code":"GB","type":"company","lineage":["https://openalex.org/I103017756","https://openalex.org/I4210154917"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Mainwaring","raw_affiliation_strings":["Pall Europe, Portsmouth, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pall Europe, Portsmouth, UK","institution_ids":["https://openalex.org/I4210154917"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101097270","display_name":"Amar Joshi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210154917","display_name":"Pall Corporation (United Kingdom)","ror":"https://ror.org/04hw9y579","country_code":"GB","type":"company","lineage":["https://openalex.org/I103017756","https://openalex.org/I4210154917"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Amar Joshi","raw_affiliation_strings":["Pall Europe, Portsmouth, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pall Europe, Portsmouth, UK","institution_ids":["https://openalex.org/I4210154917"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053425562","display_name":"Paul Cashen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210154917","display_name":"Pall Corporation (United Kingdom)","ror":"https://ror.org/04hw9y579","country_code":"GB","type":"company","lineage":["https://openalex.org/I103017756","https://openalex.org/I4210154917"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul Cashen","raw_affiliation_strings":["Pall Europe, Portsmouth, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pall Europe, Portsmouth, UK","institution_ids":["https://openalex.org/I4210154917"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032263434","display_name":"Byron Rees","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210154917","display_name":"Pall Corporation (United Kingdom)","ror":"https://ror.org/04hw9y579","country_code":"GB","type":"company","lineage":["https://openalex.org/I103017756","https://openalex.org/I4210154917"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Byron Rees","raw_affiliation_strings":["Pall Europe, Portsmouth, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pall Europe, Portsmouth, UK","institution_ids":["https://openalex.org/I4210154917"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Nitin Chopra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117289","display_name":"Sartorius (Germany)","ror":"https://ror.org/01nvz9x61","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210117289"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nitin Chopra","raw_affiliation_strings":["Sartorius Stedim Biotech GmbH, Goettingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sartorius Stedim Biotech GmbH, Goettingen, Germany","institution_ids":["https://openalex.org/I4210117289"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038667460","display_name":"Piergiuseppe Nestola","orcid":"https://orcid.org/0000-0003-3186-5149","observed_orcids":["https://orcid.org/0000-0003-3186-5149"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Piergiuseppe Nestola","raw_affiliation_strings":["Sartorius Stedim Switzerland AG, Tagelswangen, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sartorius Stedim Switzerland AG, Tagelswangen, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038320022","display_name":"Jonathan Humphreys","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan Humphreys","raw_affiliation_strings":["Vaccine Manufacturing and Innovation Centre, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccine Manufacturing and Innovation Centre, Oxford, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101470674","display_name":"Sarah Davies","orcid":"https://orcid.org/0000-0003-1487-5863","observed_orcids":["https://orcid.org/0000-0003-1487-5863"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah Davies","raw_affiliation_strings":["Cobra Biologics, Keele, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cobra Biologics, Keele, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004147050","display_name":"Nick Smith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nick Smith","raw_affiliation_strings":["Cobra Biologics, Keele, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cobra Biologics, Keele, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Scott Bruce","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott Bruce","raw_affiliation_strings":["Cobra Biologics, Keele, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cobra Biologics, Keele, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034553581","display_name":"Dennis J. Verbart","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dennis Verbart","raw_affiliation_strings":["Halix BV, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Halix BV, Leiden, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012223853","display_name":"Daan Bormans","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daan Bormans","raw_affiliation_strings":["Halix BV, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Halix BV, Leiden, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002923430","display_name":"Carol Knevelman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146357","display_name":"Oxford BioMedica (United Kingdom)","ror":"https://ror.org/03dp0vf82","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210146357"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Carol Knevelman","raw_affiliation_strings":["Oxford Biomedica PLC, Cowley, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxford Biomedica PLC, Cowley, UK","institution_ids":["https://openalex.org/I4210146357"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079410056","display_name":"Mark Woodyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146357","display_name":"Oxford BioMedica (United Kingdom)","ror":"https://ror.org/03dp0vf82","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210146357"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark Woodyer","raw_affiliation_strings":["Oxford Biomedica PLC, Cowley, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxford Biomedica PLC, Cowley, UK","institution_ids":["https://openalex.org/I4210146357"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111000981","display_name":"Lee Davies","orcid":"https://orcid.org/0009-0004-9361-2651","observed_orcids":["https://orcid.org/0009-0004-9361-2651"]},"institutions":[{"id":"https://openalex.org/I4210146357","display_name":"Oxford BioMedica (United Kingdom)","ror":"https://ror.org/03dp0vf82","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210146357"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lee Davies","raw_affiliation_strings":["Oxford Biomedica PLC, Cowley, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxford Biomedica PLC, Cowley, UK","institution_ids":["https://openalex.org/I4210146357"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lisa Cooper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146357","display_name":"Oxford BioMedica (United Kingdom)","ror":"https://ror.org/03dp0vf82","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210146357"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lisa Cooper","raw_affiliation_strings":["Oxford Biomedica PLC, Cowley, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxford Biomedica PLC, Cowley, UK","institution_ids":["https://openalex.org/I4210146357"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013775035","display_name":"Maria Kapanidou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146357","display_name":"Oxford BioMedica (United Kingdom)","ror":"https://ror.org/03dp0vf82","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210146357"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Maria Kapanidou","raw_affiliation_strings":["Oxford Biomedica PLC, Cowley, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxford Biomedica PLC, Cowley, UK","institution_ids":["https://openalex.org/I4210146357"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076658221","display_name":"Nicole A. Bleckwenn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole Bleckwenn","raw_affiliation_strings":["Biopharmaceuticals Development R&D, AstraZeneca Gaithersburg Maryland USA","Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceuticals Development R&D, AstraZeneca Gaithersburg Maryland USA","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Daniel Pappas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Pappas","raw_affiliation_strings":["Biopharmaceuticals Development R&D, AstraZeneca Gaithersburg Maryland USA","Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceuticals Development R&D, AstraZeneca Gaithersburg Maryland USA","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000793343","display_name":"Teresa Lambe","orcid":"https://orcid.org/0000-0001-7711-897X","observed_orcids":["https://orcid.org/0000-0001-7711-897X"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210153742","display_name":"Jenner Institute","ror":"https://ror.org/05kwhph67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210153742"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Teresa Lambe","raw_affiliation_strings":["Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210153742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024264885","display_name":"Daniel Carlton Smith","orcid":"https://orcid.org/0009-0002-8283-3227","observed_orcids":["https://orcid.org/0009-0002-8283-3227"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel C. Smith","raw_affiliation_strings":["Cobra Biologics, Keele, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cobra Biologics, Keele, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047085385","display_name":"Catherine Green","orcid":"https://orcid.org/0000-0002-7068-7106","observed_orcids":["https://orcid.org/0000-0002-7068-7106"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Catherine M. Green","raw_affiliation_strings":["Clinical Biomanufacturing Facility, Nuffield Department of Medicine, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Biomanufacturing Facility, Nuffield Department of Medicine, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090237172","display_name":"Raghavan V. Venkat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raghavan Venkat","raw_affiliation_strings":["Biopharmaceuticals Development R&D, AstraZeneca Gaithersburg Maryland USA","Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceuticals Development R&D, AstraZeneca Gaithersburg Maryland USA","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031692949","display_name":"Adam John Ritchie","orcid":"https://orcid.org/0000-0003-1173-4408","observed_orcids":["https://orcid.org/0000-0003-1173-4408"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210153742","display_name":"Jenner Institute","ror":"https://ror.org/05kwhph67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210153742"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adam J. Ritchie","raw_affiliation_strings":["Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210153742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057807377","display_name":"Sarah C. Gilbert","orcid":"https://orcid.org/0000-0002-6823-9750","observed_orcids":["https://orcid.org/0000-0002-6823-9750"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210153742","display_name":"Jenner Institute","ror":"https://ror.org/05kwhph67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210153742"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah C. Gilbert","raw_affiliation_strings":["Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210153742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102810679","display_name":"Richard C Turner","orcid":"https://orcid.org/0000-0001-9692-4360","observed_orcids":["https://orcid.org/0000-0001-9692-4360"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Richard Turner","raw_affiliation_strings":["Purification Process Sciences, Biopharmaceuticals Development R&D, AstraZeneca Cambridge UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Purification Process Sciences, Biopharmaceuticals Development R&D, AstraZeneca Cambridge UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064651300","display_name":"Alexander D. Douglas","orcid":"https://orcid.org/0000-0002-5410-7562","observed_orcids":["https://orcid.org/0000-0002-5410-7562"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210153742","display_name":"Jenner Institute","ror":"https://ror.org/05kwhph67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210153742"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Alexander D. Douglas","raw_affiliation_strings":["Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK"],"raw_orcid":"https://orcid.org/0000-0002-5410-7562","affiliations":[{"raw_affiliation_string":"Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210153742"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5064651300"],"corresponding_institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210153742"],"apc_list":{"value":4600,"currency":"USD","value_usd":4600},"apc_paid":{"value":4600,"currency":"USD","value_usd":4600},"fwci":3.5527,"has_fulltext":true,"cited_by_count":67,"citation_normalized_percentile":{"value":0.94528769,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"119","issue":"1","first_page":"48","last_page":"58"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.6718999743461609,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.6718999743461609,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.18870000541210175,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11663","display_name":"Viral Infectious Diseases and Gene Expression in Insects","score":0.1266999989748001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chadox1-ncov-19-vaccine","display_name":"ChAdOx1 nCoV-19 vaccine","score":0.9629999995231628},{"id":"https://openalex.org/keywords/azd1222","display_name":"AZD1222","score":0.9660000205039978},{"id":"https://openalex.org/keywords/adenovirus-vectored-vaccine","display_name":"adenovirus vector vaccine","score":0.8519999980926514},{"id":"https://openalex.org/keywords/covid-19-vaccines","display_name":"COVID-19 vaccines","score":0.8980000019073486},{"id":"https://openalex.org/keywords/vaccine-production","display_name":"vaccine production","score":0.7400000095367432},{"id":"https://openalex.org/keywords/mass-production","display_name":"mass production","score":0.6639999747276306},{"id":"https://openalex.org/keywords/distributed-manufacturing","display_name":"distributed manufacturing","score":0.8700000047683716},{"id":"https://openalex.org/keywords/process-economics","display_name":"process economics","score":0.8009999990463257},{"id":"https://openalex.org/keywords/covid-19-vaccine-rollout","display_name":"COVID-19 vaccine rollout","score":0.8320000171661377}],"concepts":[{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.6685388088226318},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.6592748761177063},{"id":"https://openalex.org/C188198153","wikidata":"https://www.wikidata.org/wiki/Q1613840","display_name":"Limiting","level":2,"score":0.656552255153656},{"id":"https://openalex.org/C2987875673","wikidata":"https://www.wikidata.org/wiki/Q187939","display_name":"Manufacturing process","level":2,"score":0.6274778842926025},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.6263824105262756},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5494120717048645},{"id":"https://openalex.org/C2778755073","wikidata":"https://www.wikidata.org/wiki/Q10858537","display_name":"Scale (ratio)","level":2,"score":0.5380098223686218},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.5314539670944214},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.4885174036026001},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.4603329598903656},{"id":"https://openalex.org/C92087593","wikidata":"https://www.wikidata.org/wiki/Q427389","display_name":"Vector (molecular biology)","level":4,"score":0.4571021795272827},{"id":"https://openalex.org/C2778348673","wikidata":"https://www.wikidata.org/wiki/Q739302","display_name":"Production (economics)","level":2,"score":0.4545818865299225},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3716226816177368},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.35138845443725586},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27942490577697754},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.260967880487442},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22978627681732178},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.16961157321929932},{"id":"https://openalex.org/C205649164","wikidata":"https://www.wikidata.org/wiki/Q1071","display_name":"Geography","level":0,"score":0.14055708050727844},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.1165112555027008},{"id":"https://openalex.org/C58640448","wikidata":"https://www.wikidata.org/wiki/Q42515","display_name":"Cartography","level":1,"score":0.08702364563941956},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.07191956043243408},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000086663","descriptor_name":"COVID-19 Vaccines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000087506","descriptor_name":"Vaccine Development","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000090985","descriptor_name":"ChAdOx1 nCoV-19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002679","descriptor_name":"Pan troglodytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004926","descriptor_name":"Escherichia coli","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005843","descriptor_name":"Geography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014611","descriptor_name":"Vaccination","qualifier_ui":"Q000295","qualifier_name":"instrumentation","is_major_topic":false},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/bit.27945","doi":"https://doi.org/10.1002/bit.27945","is_oa":true,"landing_page_url":"https://doi.org/10.1002/bit.27945","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bit.27945","source":{"id":"https://openalex.org/S151564723","display_name":"Biotechnology and Bioengineering","issn_l":"0006-3592","issn":["0006-3592","1097-0290"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnology and Bioengineering","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8653296","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8653296","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnol Bioeng","raw_type":"Text"},{"id":"pmid:34585736","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34585736","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnology and bioengineering","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/bit.27945","doi":"https://doi.org/10.1002/bit.27945","is_oa":true,"landing_page_url":"https://doi.org/10.1002/bit.27945","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bit.27945","source":{"id":"https://openalex.org/S151564723","display_name":"Biotechnology and Bioengineering","issn_l":"0006-3592","issn":["0006-3592","1097-0290"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnology and Bioengineering","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/9","display_name":"Industry, innovation and infrastructure","score":0.6773999929428101},{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2718309710","display_name":"GMP manufacture and Phase I clinical trial of a thermostable single-dose rabies vaccine for pre-exposure prophylaxis for children in endemic areas","funder_award_id":"MR/P017339/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G339412483","display_name":"The Future Vaccine Manufacturing Research Hub (Vax-Hub)","funder_award_id":"EP/R013756/1","funder_id":"https://openalex.org/F4320334627","funder_display_name":"Engineering and Physical Sciences Research Council"},{"id":"https://openalex.org/G5527493725","display_name":"UoOxford Confidence in Concept 2013","funder_award_id":"MC_PC_13073","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G6257416480","display_name":null,"funder_award_id":"MC_PC_19058","funder_id":"https://openalex.org/F4320314731","funder_display_name":"UK Research and Innovation"},{"id":"https://openalex.org/G8499567441","display_name":"Covid-19 Vaccine","funder_award_id":"COV19OxfordVaccine01","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320314731","display_name":"UK Research and Innovation","ror":"https://ror.org/001aqnf71"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"},{"id":"https://openalex.org/F4320334627","display_name":"Engineering and Physical Sciences Research Council","ror":"https://ror.org/0439y7842"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3203037871.pdf","grobid_xml":"https://content.openalex.org/works/W3203037871.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1506151812","https://openalex.org/W1968934590","https://openalex.org/W1970627059","https://openalex.org/W1978473493","https://openalex.org/W2013245408","https://openalex.org/W2020405271","https://openalex.org/W2084976117","https://openalex.org/W2105595963","https://openalex.org/W2123906885","https://openalex.org/W2286739232","https://openalex.org/W2345418757","https://openalex.org/W2519763881","https://openalex.org/W2766598255","https://openalex.org/W2940832079","https://openalex.org/W2943635785","https://openalex.org/W3045724532","https://openalex.org/W3111590711"],"related_works":["https://openalex.org/W3183558771","https://openalex.org/W3207927300","https://openalex.org/W4200285665","https://openalex.org/W4387002094","https://openalex.org/W3193751414","https://openalex.org/W7163581590","https://openalex.org/W3134263496","https://openalex.org/W3204269207","https://openalex.org/W4385668781","https://openalex.org/W4313294846"],"abstract_inverted_index":{"Manufacturing":[0],"has":[1],"been":[2],"the":[3,11,41,47,56,69,73,82,98],"key":[4],"factor":[5],"limiting":[6],"rollout":[7],"of":[8,20,43,49,91,110],"vaccination":[9],"during":[10],"COVID-19":[12,112],"pandemic,":[13],"requiring":[14],"rapid":[15],"development":[16,42],"and":[17,52,72,87],"large-scale":[18,65],"implementation":[19],"novel":[21,60],"manufacturing":[22,102],"technologies.":[23],"ChAdOx1":[24],"nCoV-19":[25],"(AZD1222,":[26],"Vaxzevria)":[27],"is":[28],"an":[29,36],"efficacious":[30],"vaccine":[31,51,83,113],"against":[32],"SARS-CoV-2,":[33],"based":[34,54],"upon":[35,55],"adenovirus":[37],"vector.":[38],"We":[39,67],"describe":[40],"a":[44,107],"process":[45,70],"for":[46],"production":[48],"this":[50],"others":[53],"same":[57],"platform,":[58],"including":[59],"features":[61],"to":[62,80,104],"facilitate":[63],"very":[64],"production.":[66],"discuss":[68],"economics":[71],"\"distributed":[74],"manufacturing\"":[75],"approach":[76],"we":[77],"have":[78,96],"taken":[79],"provide":[81],"at":[84,115],"globally-relevant":[85],"scale":[86],"with":[88],"international":[89],"security":[90],"supply.":[92],"Together,":[93],"these":[94],"approaches":[95],"enabled":[97],"largest":[99],"viral":[100],"vector":[101],"campaign":[103],"date,":[105],"providing":[106],"substantial":[108],"proportion":[109],"global":[111],"supply":[114],"low":[116],"cost.":[117]},"counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":23},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2021-10-11T00:00:00"}